VENTXP7

Across TCGA pan-cancer cohorts, VENTXP7 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated VENTXP7 data layer compared with 2 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher VENTXP7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VENTXP7 expression acts as an unfavorable survival marker, although some lineages such as UCS and HNSC show a favorable association.

KIRC, THCA, and UCS are the cancer types where VENTXP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.517	0.680	<.001	149	view →
THCA	OS	Tertile	II,III,IV	0.607	0.909	<.001	81	view →
UCS	DFS	Tertile	III,IV	1.000	0.199	.012	48	view →
HNSC	OS	Tertile	All	0.892	0.669	.013	45	view →
CESC	OS	Tertile	III,IV	0.373	0.700	.012	36	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	24	view →
SARC	OS	Tertile	All	0.601	0.763	.012	18	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	18	view →
LUSC	DFS	Tertile	III,IV	0.671	0.316	.025	18	view →
LIHC	DFS	Tertile	All	0.367	0.569	.013	15	view →
ESCA	OS	Tertile	III,IV	0.673	0.346	.039	8	view →
BLCA	OS	Tertile	All	0.685	0.319	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

VENTXP7–KIRC (OS)

Open the KIRC breakdown →